Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain
Completed
Boehringer Ingelheim
Phase 3
The aim of the study is to assess the efficacy of Buscopan® (hyoscine butylbromide) in
comparison to 654-II (anisodamine)in acute gastric or intestinal spasm-like pain.
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
Unknown status
Wanqing Gu
Phase 1/Phase 2
RATIONALE:Anticholinesterase drugs and cholinergic M receptor antagonist are applied to
patients who have obstructive jaundice after operation.
PURPOSE:This clinical trial was designed to lower the incidence and mortality of operation
complications in patients with obstructive jaundice .
Anisodamine has been widely used in China for its pharmacological effect on improving
microcirculation during shock. It has been reported that anisodamine is effective in reducing
mortality rate in children with meningitis. however, its effectiveness in patients with
septic shock has not been systematically investigated. The aim of the study is to investigate
the effectiveness of anisodamine in the treatment of patients with septic shock.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
